How to turn EU regulatory reform into a platform for industrial and clinical leadership from Spanish subsidiaries. By Ehab Soltan HoyLunes – Europe is redefining the rules of the pharmaceutical game. The combination of EU legislative reform, the progressive implementation of the Health Technology Assessment (HTA) Regulation, and the consolidation of the European Medicines Agency’s (EMA) scientific role is…
Read MoreSpain in the New European Pharmaceutical Architecture: A Strategic Opportunity for Multinationals
